Skip to main content
OpenTrials
Completed

NCT Number: NCT04922879

Early Lung Rehabilitation Care for Patients After Double Lung Transplantation

Develop appropriate individual programs for patients to implement lung rehabilitation safely and effectively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

SAHZhejiangU

Hangzhou, Zhejiang, 310000, China

About this study

Early respiratory function training, reasonable oxygen therapy to prevent hypoxemia, Positive pressure vibration training to promote coughing ability recovery, early exercise, Health education and psychological support.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients after double lung transplantation; informed consent

Exclusion criteria

  • unstable condition

Treatment and study plan

Individualized lung rehabilitation

Behavioral

Early respiratory function training, reasonable oxygen therapy to prevent hypoxemia, Positive pressure vibration training to promote coughing ability recovery, early exercise, Health education and psychological support.

Primary outcomes

  1. ICU hospital stay

    Time frame: 1 year

    the stay time spent in ICU

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Jun 11, 2021
Registry last updated
Jun 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.